UNIQA Biztosito Zrt.:企業の戦略・SWOT・財務情報

◆英語タイトル:UNIQA Biztosito Zrt. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C9127
◆発行会社(調査会社):MarketLine
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ハンガリー
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

UNIQA Biztosito Zrt. – Strategy, SWOT and Corporate Finance Report
Summary

UNIQA Biztosito Zrt. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

UNIQA Biztosito Zrt. (UNIQA Biztosito), a part of UNIQA Group, is a provider of insurance solutions. The company provides a range of life and non-life insurance products to individuals and corporate customers. Its portfolio of products includes traditional life insurance, term life insurance plans, unit-linked life insurance, health insurance, property insurance, art insurance, accident insurance, and vehicle insurance. It also offers legal expenses insurance, group health insurance, retirement and pension plans, travel insurance, liability insurance, small boat insurance, technical insurance, and cargo insurance. The company distributes its products through a network of sales personnel, brokers, general agencies, and banking partners. UNIQA Biztosito is headquartered in Budapest, Hungary.

UNIQA Biztosito reported gross premium written of HUF64.5 million for the fiscal year ended December 2017 (FY2017), an increase of 10.1% over that in FY2016. Its net premiums written were HUF44.7 million in FY2017, an increase of 8.7% over that in FY2016.

Scope

- Detailed information on UNIQA Biztosito Zrt. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting UNIQA Biztosito Zrt. in the form of a SWOT analysis
- An in-depth view of the business model of UNIQA Biztosito Zrt. including a breakdown and examination of key business segments
- Intelligence on UNIQA Biztosito Zrt.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about UNIQA Biztosito Zrt., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of UNIQA Biztosito Zrt. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess UNIQA Biztosito Zrt. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on UNIQA Biztosito Zrt.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
UNIQA Biztosito Zrt.: Company Overview 6
UNIQA Biztosito Zrt.: Overview and Key Facts 6
UNIQA Biztosito Zrt.: Overview 6
UNIQA Biztosito Zrt.: Key Facts 6
UNIQA Biztosito Zrt.: Key Employees 7
UNIQA Biztosito Zrt.: Major Products and Services 8
UNIQA Biztosito Zrt.: Company History 9
UNIQA Biztosito Zrt.: Locations and Subsidiaries 10
UNIQA Biztosito Zrt.: Key Competitors 11
UNIQA Biztosito Zrt.: Company Analysis 12
UNIQA Biztosito Zrt.: Business Description 12
UNIQA Biztosito Zrt.: SWOT Analysis 13
UNIQA Biztosito Zrt.: SWOT Overview 13
UNIQA Biztosito Zrt.: Strengths 13
UNIQA Biztosito Zrt.: Weaknesses 14
UNIQA Biztosito Zrt.: Opportunities 14
UNIQA Biztosito Zrt.: Threats 14
Appendix 16
Contact Us 16
Methodology 16
About MarketLine 17

List of Tables
Table 1: UNIQA Biztosito Zrt.: Key Facts
Table 2: UNIQA Biztosito Zrt.: Key Employees
Table 3: UNIQA Biztosito Zrt.: Company History
Table 4: UNIQA Biztosito Zrt.: Locations and Subsidiaries
Table 5: UNIQA Biztosito Zrt.: Key Competitors



★海外企業調査レポート[UNIQA Biztosito Zrt.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SELEX Galileo Inc.:企業の戦略・SWOT・財務情報
    SELEX Galileo Inc. - Strategy, SWOT and Corporate Finance Report Summary SELEX Galileo Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Fate Therapeutics Inc (FATE)-製薬・医療分野:企業M&A・提携分析
    Summary Fate Therapeutics Inc (Fate Therapeutics) is a biopharmaceutical company that develops programmed cellular therapies for cancer and immune disorders. The company’s pipeline product candidates include cellular immunotherapy pipeline, immuno-oncology candidates, and immuno-regulatory candidate …
  • Anhui Construction Engineering Group Co., Ltd.:企業の戦略・SWOT・財務情報
    Anhui Construction Engineering Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Anhui Construction Engineering Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Bharti Airtel Limited:企業の戦略・SWOT・財務分析
    Bharti Airtel Limited - Strategy, SWOT and Corporate Finance Report Summary Bharti Airtel Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Akonni Biosystems Inc:企業の製品パイプライン分析2018
    Summary Akonni Biosystems Inc (Akonni Biosystems) is a molecular diagnostics company that develops, manufactures, and distributes integrated molecular diagnostic systems. The company provides product such as nucleic acid extraction kits, molecular diagnostic tests, thermal cyclers, microarray reader …
  • Public Service Enterprise Group Inc (PEG)-エネルギー分野:企業M&A・提携分析
    Summary Public Service Enterprise Group Inc. (PSEG) is a diversified energy holding company that generates, transmits and distributes electricity, and gas. It supplies electricity from its nuclear, fossil and renewable energy assets as part of its wholesale energy activities. The company sells elect …
  • NovaDigm Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NovaDigm Therapeutics Inc (NovaDigm) is a developer of immunotherapeutics and preventative vaccines to protect patients from fungal and bacterial diseases. The company’s products include NDV-3 vaccines, vaccine clinical supplies, ALS3 vaccines, bacterial and fungal vaccine antigens, fungal a …
  • Gujarat State Petroleum Corp Ltd:企業の戦略的SWOT分析
    Gujarat State Petroleum Corp Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • ABITEC Corp:企業の戦略的SWOT分析
    ABITEC Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • FTI Consulting, Inc.:企業の戦略・SWOT・財務情報
    FTI Consulting, Inc. - Strategy, SWOT and Corporate Finance Report Summary FTI Consulting, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Kezar Life Sciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Kezar Life Sciences Inc (Kezar) is a biotech company that discovers and develops therapies for protein homeostasis. The company’s development program includes KZR-616, a selective small molecule inhibitor of the immunoproteasome. Its KZR-616 finds application in the treatment of autoimmune d …
  • Odfjell Drilling Ltd (ODL):企業の財務・戦略的SWOT分析
    Odfjell Drilling Ltd (ODL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Prolung Inc (LUNG):医療機器:M&Aディール及び事業提携情報
    Summary Prolung Inc(Prolung) formerly known as Fresh Medical Laboratories Inc, is a medical device company that offers diagnostic services. The company offers electro pulmonary nodule scanner system used for the non invasive early diagnostics of different types of diseases. Its EPN system consists o …
  • KVK-Tech Inc-製薬・医療分野:企業M&A・提携分析
    Summary KVK-Tech Inc (KVK-Tech) is a manufacturer and marketer generic drugs. The company's product portfolio includes benzphetamine HCL, betaxolol, chlorphen-12, cyclobenzaprine HCL, diethylpropion HCL, hydroxyzine HCL, indomethacin extended release, phendimetrazine tartrate, phentermine HCL, prome …
  • Competitive Power Ventures Inc:企業の戦略的SWOT分析
    Competitive Power Ventures Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Myriad Genetics Inc (MYGN):製薬・医療:M&Aディール及び事業提携情報
    Summary Myriad Genetics Inc (Myriad) is a specialty molecular diagnostic company, which discovers and commercializes molecular diagnostic tests, personalized medicine and services for major diseases. The company’s product portfolio includes molecular diagnostic testing products that analyze genes, t …
  • NexTier Oilfield Solutions Inc (NEX):企業の財務・戦略的SWOT分析
    NexTier Oilfield Solutions Inc (NEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • PT. Millennium Pharmacon International TBK (SDPC):企業の財務・戦略的SWOT分析
    PT. Millennium Pharmacon International TBK (SDPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • The Boston Beer Co Inc (SAM):企業の財務・戦略的SWOT分析
    The Boston Beer Co Inc (SAM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Yum China Holdings Inc (YUMC):企業の財務・戦略的SWOT分析
    Yum China Holdings Inc (YUMC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆